These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 16536868)
1. The impact of smoking on adherence to treatment for latent tuberculosis infection. Lavigne M; Rocher I; Steensma C; Brassard P BMC Public Health; 2006 Mar; 6():66. PubMed ID: 16536868 [TBL] [Abstract][Full Text] [Related]
2. Risk factors for failure to complete a course of latent tuberculosis infection treatment in Salvador, Brazil. Machado A; Finkmoore B; Emodi K; Takenami I; Barbosa T; Tavares M; Reis MG; Arruda S; Riley LW Int J Tuberc Lung Dis; 2009 Jun; 13(6):719-25. PubMed ID: 19460247 [TBL] [Abstract][Full Text] [Related]
3. Predicting non-completion of treatment for latent tuberculous infection: a prospective survey. Shieh FK; Snyder G; Horsburgh CR; Bernardo J; Murphy C; Saukkonen JJ Am J Respir Crit Care Med; 2006 Sep; 174(6):717-21. PubMed ID: 16809632 [TBL] [Abstract][Full Text] [Related]
4. Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa. Szakacs TA; Wilson D; Cameron DW; Clark M; Kocheleff P; Muller FJ; McCarthy AE BMC Infect Dis; 2006 Jun; 6():97. PubMed ID: 16772037 [TBL] [Abstract][Full Text] [Related]
5. Adherence to treatment of latent tuberculosis infection in a clinical population in New York City. Li J; Munsiff SS; Tarantino T; Dorsinville M Int J Infect Dis; 2010 Apr; 14(4):e292-7. PubMed ID: 19656705 [TBL] [Abstract][Full Text] [Related]
6. Improved adherence and less toxicity with rifampin vs isoniazid for treatment of latent tuberculosis: a retrospective study. Page KR; Sifakis F; Montes de Oca R; Cronin WA; Doherty MC; Federline L; Bur S; Walsh T; Karney W; Milman J; Baruch N; Adelakun A; Dorman SE Arch Intern Med; 2006 Sep; 166(17):1863-70. PubMed ID: 17000943 [TBL] [Abstract][Full Text] [Related]
7. Adherence to latent tuberculosis infection therapy among latino immigrants. Ailinger RL; Moore JB; Nguyen N; Lasus H Public Health Nurs; 2006; 23(4):307-13. PubMed ID: 16817801 [TBL] [Abstract][Full Text] [Related]
8. Acceptance of screening and completion of treatment for latent tuberculosis infection among refugee claimants in Canada. Levesque JF; Dongier P; Brassard P; Allard R Int J Tuberc Lung Dis; 2004 Jun; 8(6):711-7. PubMed ID: 15182140 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with failure to complete isoniazid treatment for latent tuberculosis infection in Rhode Island. Kwara A; Herold JS; Machan JT; Carter EJ Chest; 2008 Apr; 133(4):862-8. PubMed ID: 18071014 [TBL] [Abstract][Full Text] [Related]
10. Association between smoking status, other factors and tuberculosis treatment failure in Morocco. Tachfouti N; Nejjari C; Benjelloun MC; Berraho M; Elfakir S; El Rhazi K; Slama K Int J Tuberc Lung Dis; 2011 Jun; 15(6):838-43. PubMed ID: 21575308 [TBL] [Abstract][Full Text] [Related]
11. Evaluating the role of primary care physicians in the treatment of latent tuberculosis: a population study. Rubinowicz A; Bartlett G; MacGibbon B; Greenaway C; Ronald L; Munoz M; Menzies D Int J Tuberc Lung Dis; 2014 Dec; 18(12):1449-54. PubMed ID: 25517810 [TBL] [Abstract][Full Text] [Related]
12. Latent tuberculosis infection treatment for prison inmates: a randomised controlled trial. Chan PC; Yang CH; Chang LY; Wang KF; Lu BY; Lu CY; Shao PL; Hsueh PR; Fang CT; Huang LM Int J Tuberc Lung Dis; 2012 May; 16(5):633-8. PubMed ID: 22410137 [TBL] [Abstract][Full Text] [Related]
13. Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment. Trajman A; Long R; Zylberberg D; Dion MJ; Al-Otaibi B; Menzies D Int J Tuberc Lung Dis; 2010 May; 14(5):551-9. PubMed ID: 20392347 [TBL] [Abstract][Full Text] [Related]
14. Treatment completion in latent tuberculosis infection at specialist tuberculosis units in Spain. Anibarro L; Casas S; Paz-Esquete J; Gonzalez L; Pena A; Guerra MR; Sande D; Calviño L; Santin M; Int J Tuberc Lung Dis; 2010 Jun; 14(6):701-7. PubMed ID: 20487607 [TBL] [Abstract][Full Text] [Related]
15. Yield of tuberculin screening among injection drug users. Brassard P; Bruneau J; Schwartzman K; Sénécal M; Menzies D Int J Tuberc Lung Dis; 2004 Aug; 8(8):988-93. PubMed ID: 15305482 [TBL] [Abstract][Full Text] [Related]
16. No evidence for multiple-drug prophylaxis for tuberculosis compared with isoniazid alone in Southeast Asian refugees and migrants: completion and compliance are major determinants of effectiveness. MacIntyre CR; Ansari MZ; Carnie J; Hart WG Prev Med; 2000 May; 30(5):425-32. PubMed ID: 10845752 [TBL] [Abstract][Full Text] [Related]
17. [Compliance with latent tuberculosis treatment: a public health challenge]. Bishara H; Ore L; Ravell DW Harefuah; 2014; 153(3-4):167-70, 239, 238. PubMed ID: 24791558 [TBL] [Abstract][Full Text] [Related]
18. Current treatment options for latent tuberculosis infection. Bocchino M; Matarese A; Sanduzzi A J Rheumatol Suppl; 2014 May; 91():71-7. PubMed ID: 24789003 [TBL] [Abstract][Full Text] [Related]
20. Active case finding and prevention of tuberculosis among a cohort of contacts exposed to infectious tuberculosis cases in New York City. Anger HA; Proops D; Harris TG; Li J; Kreiswirth BN; Shashkina E; Ahuja SD Clin Infect Dis; 2012 May; 54(9):1287-95. PubMed ID: 22412056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]